Medical cannabis could save NHS £4 billion each year
Allowing medical cannabis to be prescribed on the NHS for chronic pain could save the state healthcare provider almost £4 billion annually,
top of page
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
James Bunn
Jul 312 min read
Suicidal Ideation in Medicinal Cannabis Patients: A 12-Month Prospective Study
To document the prevalence and correlates of suicidal ideation (SI) among individuals seeking cannabis-based medicinal products (CBMPs); to
Michael Lynskey
Jun 172 min read
Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well‑Being: Findings from T21
There are important differences between individuals aged 65+ years and younger individuals receiving cannabis-based medicinal products. Olde
Alkyoni Anthanasiou-Fragkouli
Jun 62 min read
Prescribed Medicinal Cannabis for the Treatment of Chronic Pain Comorbid with Depression: Real World Evidence from Project Twenty21
Chronic pain is one of the most common conditions for which people seek treatment with cannabis-based medicinal products (CBMPs) and there i
Dr Anne Schlag, Professor David Nutt and more
Mar 121 min read
Medicinal cannabis for treating PTSD and comorbid depression: Real World Evidence from Project T21
Authors Michael Lynskey, Alkyoni Athanasiou-Fragkouli, Hannah Thurgur, Anne Schlag and David Nutt Published March 12, 2024 Background...
Dr Hannah Thurgur, Dr Anne Schlag, and more
Aug 31, 20231 min read
Cannabis-based medicinal products for the treatment of Long COVID symptoms: current and potential applications
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can result in a range of persistent symptoms impacting everyday funct
Dr Rose Crossin
Aug 21, 20237 min read
A drug harms ranking study for Aotearoa New Zealand
Drug harm is a significant public health burden in Aotearoa New Zealand ; though harms are not evenly distributed across the populati
Balázs Szigeti, Professor David Nutt and more
Jul 17, 20231 min read
Bayesian analysis of real-world data as evidence for drug approval: Remembering Sir Michael Rawlins
The two pillars of modern medical research are where in most randomized controlled trials (RCTs), the active treatment is compared with plac
Rayyan Zafar, Maxim Siegel and more
Jun 12, 20231 min read
Psychedelic therapy in the treatment of addiction: the past, present and future
Psychedelic therapy has witnessed a resurgence in interest in the last decade from the scientific and medical communities with evidence now
Kylie O’Brien, Justin Beilby and more
Mar 23, 20232 min read
Preliminary findings from T21 Australia
An observational study of patients prescribed medicinal Cannabis for chronic pain, anxiety, posttraumatic stress disorder and multiple...
Professor Michael Lynskey, Dr Anne Schlag and more
Nov 3, 20224 min read
The value of real world evidence: The case of medical cannabis
Authors Anne Katrin Schlag, Rayyan Zafar, Michael Lynskey, Lawrence D Phillips, Alkyoni Athanasiou-Fragkouli, David J Nutt Published...
Robin Carhart-Harris and Professor David Nutt
Jul 7, 202232 min read
User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study
Authors Robin Carhart-Harris, David Nutt Published July 30, 2010 Abstract This study used a web-based questionnaire to investigate user...
Dr Anne Schlag, Professor David Nutt and more
Jun 21, 20222 min read
Cannabinoids and the endocannabinoid system in fibromyalgia: a review of preclinical and clinical research
Authors Stephanie Bourke, Anne Schlag, Saoirse Elizabeth O’Sullivan, David Nutt, David Finn Published May 21, 2022 Fibromyalgia affects...
Dr Anne Schlag, Professor David Nutt and more
Jun 13, 20223 min read
Characteristics of People Seeking Prescribed Cannabinoids for the Treatment of Chronic Pain: Evidence From Project Twenty 21
Authors Anne Katrin Schlag, Michael Lynskey, Alan Fayaz, Alkyoni Athanasiou-Fragkouli, Brigitta Brandner, Barbara Haja, Elizabeth Iveson...
Gillian Shorter, Magdalena Harris and more
May 6, 20221 min read
The UK's first unsanctioned overdose prevention site; A proof-of-concept evaluation
Authors Gillian W Shorter, Magdalena Harris, Andrew McAuley, Kirsten MA Trayner, Alex Stevens Published May 4, 2022 Background The United...
Dr Anne Schlag, Professor David Nutt and more
Feb 3, 20223 min read
Are psychedelics dangerous? - What the research says
Authors Anne K Schlag, Jacob Aday, Iram Salam, Jo C Neill, David J Nutt Published February 3, 2022 Psychedelic medicines are a rapidly...
Dr Anne Schlag, Professor David Nutt and more
Dec 15, 20212 min read
Medical cannabis for severe treatment resistant epilepsy in children: a case series of 10 patients
Authors Rayyan Zafar, Anne Schlag, Lawrence Phillips, David J Nutt Published December 15, 2021 We previously reported on the legalisation...
Dr Anne Schlag, Professor David Nutt and more
May 18, 20212 min read
Controversies in Medical Cannabis
Authors Anne Katrin Schlag, Saoirse E. O’Sullivan, Rayyan R. Zafar, David J.Nutt Published May 18, 2021 Knowledge about the therapeutic...
Balázs Szigeti, Professor David Nutt and more
Mar 2, 20212 min read
Psychedelic Microdosing - Just a Placebo Effect?
Authors: Balázs Szigeti, Laura Kartner, Allan Blemings, Fernando Rosas, Amanda Feilding, David J. Nutt, Robin L. Carhart-Harris, David...
Dr Anne Schlag, Professor David Nutt and more
Feb 17, 20212 min read
Medical cannabis dependence: A critical review of issues and evidence
Authors: Anne K Schlag, Chandni Hindocha, Rayyan Zafar, David J Nutt, H Valerie Curran Published: February 17, 2021 This Drug Science...
Dr Anne Schlag, Professor David Nutt and more
Sep 22, 20202 min read
So near yet so far: why won’t the UK prescribe medical cannabis?
Authors: David Nutt, Steve Bazire, Lawrence D Phillips, Anne Katrin Schlag Published: September 21, 2020 This Drug Science research was...
bottom of page